These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 28791387

  • 1. Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
    Meryet-Figuière M, Lecerf C, Varin E, Coll JL, Louis MH, Dutoit S, Giffard F, Blanc-Fournier C, Hedir S, Vigneron N, Brotin E, Pelletier L, Josserand V, Denoyelle C, Poulain L.
    Oncol Rep; 2017 Oct; 38(4):1949-1958. PubMed ID: 28791387
    [Abstract] [Full Text] [Related]

  • 2. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K, Takei Y.
    Int J Cancer; 2009 Dec 15; 125(12):2978-90. PubMed ID: 19422046
    [Abstract] [Full Text] [Related]

  • 3. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects.
    Yuan Y, Makita N, Cao D, Mihara K, Kadomatsu K, Takei Y.
    Nucleic Acid Ther; 2015 Apr 15; 25(2):85-94. PubMed ID: 25692652
    [Abstract] [Full Text] [Related]

  • 4. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K, N'Diaye M, Lheureux S, Loussouarn C, Dutoit S, Briand M, Giffard F, Brotin E, Blanc-Fournier C, Poulain L.
    Apoptosis; 2013 Apr 15; 18(4):492-508. PubMed ID: 23344663
    [Abstract] [Full Text] [Related]

  • 5. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
    Brotin E, Meryet-Figuière M, Simonin K, Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon P, Denoyelle C, Poulain L.
    Int J Cancer; 2010 Feb 15; 126(4):885-95. PubMed ID: 19634140
    [Abstract] [Full Text] [Related]

  • 6. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
    Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y, Kouno M, Honma K, Nagahara S, Hanai K, Sano A, Kato T, Terada M, Ochiya T.
    Nucleic Acids Res; 2004 Jul 22; 32(13):e109. PubMed ID: 15272050
    [Abstract] [Full Text] [Related]

  • 7. Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation.
    Bonnefond ML, Lambert B, Giffard F, Abeilard E, Brotin E, Louis MH, Gueye MS, Gauduchon P, Poulain L, N'Diaye M.
    Apoptosis; 2015 Apr 22; 20(4):535-50. PubMed ID: 25627260
    [Abstract] [Full Text] [Related]

  • 8. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer.
    Kawata E, Ashihara E, Kimura S, Takenaka K, Sato K, Tanaka R, Yokota A, Kamitsuji Y, Takeuchi M, Kuroda J, Tanaka F, Yoshikawa T, Maekawa T.
    Mol Cancer Ther; 2008 Sep 22; 7(9):2904-12. PubMed ID: 18790771
    [Abstract] [Full Text] [Related]

  • 9. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
    Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, Teratani T, Namatame N, Yamamoto Y, Hanai K, Kato T, Sano A, Ochiya T.
    Proc Natl Acad Sci U S A; 2005 Aug 23; 102(34):12177-82. PubMed ID: 16091473
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S, Chen X, Xiu YL, Sun KX, Zhao Y.
    PLoS One; 2015 Aug 23; 10(5):e0125714. PubMed ID: 25933027
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J, Lu Z, Wang J, Cui M, Yeung BZ, Cole DJ, Wientjes MG, Au JL.
    J Control Release; 2015 Oct 28; 216():103-10. PubMed ID: 26272765
    [Abstract] [Full Text] [Related]

  • 12. Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells.
    Verbaan FJ, Klein Klouwenberg P, van Steenis JH, Snel CJ, Boerman O, Hennink WE, Storm G.
    Int J Pharm; 2005 Nov 04; 304(1-2):185-92. PubMed ID: 16129577
    [Abstract] [Full Text] [Related]

  • 13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X, Li DC, Zhao H, Li Z, Wang JX, Zhu DM, Zhou J, Cen JN.
    Oncol Rep; 2012 Mar 04; 27(3):628-36. PubMed ID: 22200682
    [Abstract] [Full Text] [Related]

  • 14. siRNA-Based Drug Targeting Human Bcl-xL Against Cancers.
    Takei Y.
    Methods Mol Biol; 2019 Mar 04; 1974():31-40. PubMed ID: 31098993
    [Abstract] [Full Text] [Related]

  • 15. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS, Yawata T, Honke K.
    Eur J Pharm Sci; 2014 Feb 14; 52():48-61. PubMed ID: 24178005
    [Abstract] [Full Text] [Related]

  • 16. Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death.
    Kafara P, Icard P, Guillamin M, Schwartz L, Lincet H.
    J Ovarian Res; 2015 Jun 12; 8():36. PubMed ID: 26063499
    [Abstract] [Full Text] [Related]

  • 17. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
    Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T.
    Cancer Res; 2004 May 15; 64(10):3365-70. PubMed ID: 15150085
    [Abstract] [Full Text] [Related]

  • 18. Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
    Woo SM, Min KJ, Seo BR, Nam JO, Choi KS, Yoo YH, Kwon TK.
    Cell Death Dis; 2014 Nov 06; 5(11):e1514. PubMed ID: 25375379
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
    Landen CN, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK.
    Cancer Res; 2005 Aug 01; 65(15):6910-8. PubMed ID: 16061675
    [Abstract] [Full Text] [Related]

  • 20. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
    Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A.
    Gene Ther; 2005 Mar 01; 12(5):461-6. PubMed ID: 15616603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.